4Filing Date: Mar 13, 2026
Guardant Health (GH) 4: Monroe Terilyn J. bought 17,040 shares of Restricted Stock… (Mar 13, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001652956-26-000010
Total Value$0
Trades1
Insiders1
Transaction Details
Monroe Terilyn J.
Chief People Officer·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+17.04K
Price$0.00
Total Value$0
Shares Owned After17.04K
Transaction DateMar 11, 2026
Footnotes ▸
This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.
Post-Transaction Holdings
Monroe Terilyn J. · Chief People Officer
| Security | Shares | Change |
|---|---|---|
| Restricted Stock Units | 17.04K | +17.04K |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-11
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Guardant Health, Inc. (GH)
CIK: 0001576280
--- Reporting Owner ---
Name: Monroe Terilyn J.
CIK: 0001652956
Role: Officer (Chief People Officer)
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Units
Date: 2026-03-11 | Code: A (Grant or award)
Shares: +17,040 | Price: $0.00
Shares Owned After: 17,040 | Ownership: D (Direct)
Footnotes:
[F1] This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
[F2] Not applicable for Restricted Stock Units.
--- Footnotes (Complete Index) ---
F1: This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F2: Not applicable for Restricted Stock Units.
--- Signature ---
/s/ /s/ John G. Saia, as attorney-in-fact for Terilyn J. Monroe (2026-03-13)